Beaulieu E - Search Results

1

Differential regulation of matrix metalloproteinase activities in abdominal aortic aneurysms.

Annabi B, Shédid D, Ghosn P, Kenigsberg RL, Desrosiers RR, Bojanowski MW, Beaulieu E, Nassif E, Moumdjian R, Béliveau R. Annabi B, et al. Among authors: beaulieu e. J Vasc Surg. 2002 Mar;35(3):539-46. doi: 10.1067/mva.2002.121124. J Vasc Surg. 2002. PMID: 11877705 Free article.

2

Expression of matrix metalloproteinases and their inhibitors in human brain tumors.

Béliveau R, Delbecchi L, Beaulieu E, Mousseau N, Kachra Z, Berthelet F, Moumdjian R, Del Maestro R. Béliveau R, et al. Among authors: beaulieu e. Ann N Y Acad Sci. 1999;886:236-9. doi: 10.1111/j.1749-6632.1999.tb09425.x. Ann N Y Acad Sci. 1999. PMID: 10667228

3

Expression of matrix metalloproteinases and their inhibitors in human brain tumors.

Kachra Z, Beaulieu E, Delbecchi L, Mousseau N, Berthelet F, Moumdjian R, Del Maestro R, Béliveau R. Kachra Z, et al. Among authors: beaulieu e. Clin Exp Metastasis. 1999;17(7):555-66. doi: 10.1023/a:1006760632766. Clin Exp Metastasis. 1999. PMID: 10845554

4

Src-dependent phosphorylation of membrane type I matrix metalloproteinase on cytoplasmic tyrosine 573: role in endothelial and tumor cell migration.

Nyalendo C, Michaud M, Beaulieu E, Roghi C, Murphy G, Gingras D, Béliveau R. Nyalendo C, et al. Among authors: beaulieu e. J Biol Chem. 2007 May 25;282(21):15690-9. doi: 10.1074/jbc.M608045200. Epub 2007 Mar 27. J Biol Chem. 2007. PMID: 17389600 Free article.

5

Impaired tyrosine phosphorylation of membrane type 1-matrix metalloproteinase reduces tumor cell proliferation in three-dimensional matrices and abrogates tumor growth in mice.

Nyalendo C, Beaulieu E, Sartelet H, Michaud M, Fontaine N, Gingras D, Béliveau R. Nyalendo C, et al. Among authors: beaulieu e. Carcinogenesis. 2008 Aug;29(8):1655-64. doi: 10.1093/carcin/bgn159. Epub 2008 Jul 10. Carcinogenesis. 2008. PMID: 18621744

6

Matrix metalloproteinases and their inhibitors in human pituitary tumors.

Beaulieu E, Kachra Z, Mousseau N, Delbecchi L, Hardy J, Béliveau R. Beaulieu E, et al. Neurosurgery. 1999 Dec;45(6):1432-40; discussion 1440-1. doi: 10.1097/00006123-199912000-00033. Neurosurgery. 1999. PMID: 10598711

7

Matrix proteinase inhibition by AE-941, a multifunctional antiangiogenic compound.

Gingras D, Renaud A, Mousseau N, Beaulieu E, Kachra Z, Béliveau R. Gingras D, et al. Among authors: beaulieu e. Anticancer Res. 2001 Jan-Feb;21(1A):145-55. Anticancer Res. 2001. PMID: 11299728

8

Expression of multidrug-resistance P-glycoprotein (MDR1) in human brain tumors.

Demeule M, Shedid D, Beaulieu E, Del Maestro RF, Moghrabi A, Ghosn PB, Moumdjian R, Berthelet F, Béliveau R. Demeule M, et al. Among authors: beaulieu e. Int J Cancer. 2001 Jul 1;93(1):62-6. doi: 10.1002/ijc.1306. Int J Cancer. 2001. PMID: 11391622

9

The antiangiogenic agent Neovastat (AE-941) induces endothelial cell apoptosis.

Boivin D, Gendron S, Beaulieu E, Gingras D, Béliveau R. Boivin D, et al. Among authors: beaulieu e. Mol Cancer Ther. 2002 Aug;1(10):795-802. Mol Cancer Ther. 2002. PMID: 12492112

10

VEGF increases the fibrinolytic activity of endothelial cells within fibrin matrices: involvement of VEGFR-2, tissue type plasminogen activator and matrix metalloproteinases.

Ratel D, Mihoubi S, Beaulieu E, Durocher Y, Rivard GE, Gingras D, Béliveau R. Ratel D, et al. Among authors: beaulieu e. Thromb Res. 2007;121(2):203-12. doi: 10.1016/j.thromres.2007.03.024. Epub 2007 May 21. Thromb Res. 2007. PMID: 17512973 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters